Sangamo Therapeutics, Inc. (SGMO): Price and Financial Metrics

SGMO POWR Grades

• SGMO scores best on the Growth dimension, with a Growth rank ahead of 76.74% of US stocks.
• SGMO's strongest trending metric is Quality; it's been moving down over the last 179 days.
• SGMO's current lowest rank is in the Momentum metric (where it is better than 12.28% of US stocks).

SGMO Stock Summary

• Of note is the ratio of Sangamo Therapeutics Inc's sales and general administrative expense to its total operating expenses; merely 8.76% of US stocks have a lower such ratio.
• For SGMO, its debt to operating expenses ratio is greater than that reported by merely 17.34% of US equities we're observing.
• As for revenue growth, note that SGMO's revenue has grown -6.34% over the past 12 months; that beats the revenue growth of only 12.69% of US companies in our set.
• If you're looking for stocks that are quantitatively similar to Sangamo Therapeutics Inc, a group of peers worth examining would be NRIX, CNCE, XENE, BPMC, and XBIT.
• SGMO's SEC filings can be seen here. And to visit Sangamo Therapeutics Inc's official web site, go to www.sangamo.com.

SGMO Valuation Summary

• In comparison to the median Healthcare stock, SGMO's price/earnings ratio is 129.04% lower, now standing at -10.6.
• Over the past 243 months, SGMO's price/sales ratio has gone down 42.3.
• SGMO's price/sales ratio has moved down 42.3 over the prior 243 months.

Below are key valuation metrics over time for SGMO.

SGMO Growth Metrics

Its 5 year revenue growth rate is now at 258.23%.
• Its 4 year net income to common stockholders growth rate is now at -84.95%.
• Its 3 year revenue growth rate is now at 166.38%.

SGMO's revenue has moved up $30,815,000 over the prior 34 months.

The table below shows SGMO's growth in key financial areas (numbers in millions of US dollars).

Date	Revenue	Operating Cash Flow	Net Income to Common Stock
2021-12-31	110.701	-233.251	-178.286
2021-09-30	108.515	-184.832	-181.394
2021-06-30	137.715	-92.345	-135.256
2021-03-31	131.396	120.215	-124.016
2020-12-31	118.192	169.875	-120.996
2020-09-30	147.243	153.354	-75.837

SGMO's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.

• SGMO has a Quality Grade of C, ranking ahead of 46.27% of graded US stocks.
• SGMO's asset turnover comes in at 0.127 -- ranking 244th of 682 Pharmaceutical Products stocks.
• ALBO, LXRX, and ATNX are the stocks whose asset turnover ratios are most correlated with SGMO.

The table below shows SGMO's key quality metrics over time.